Search fresh public links, source activity, and ready-to-use post angles for Astrazeneca.
Fresh curated links around AstraZeneca are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
The British drugs company has ploughed £1.5bn into US pharma firm Summit Therapeutics as part of a cancer treatment research joint venture.
The equity investment comes alongside a deal to test Summit’s ivonescimab alongside potentially many AstraZeneca drugs — but doesn’t hand the pharmaceutical company any ownership r...
Delve into the AstraZeneca pipeline strategy in 2026 as its oncology franchise keeps growing and it invests in diversification. The post AstraZeneca’s pipeline strategy: building t...
Last week, it unveiled a new corporate office in Mumbai, a relocation to be closer to health and financial ecosystems
AstraZeneca and Oracle launch AI-powered real-world data trials in Abu Dhabi, accelerating recruitment and safety monitoring across multiple diseases
Tezspire succeeded in a study in eosinophilic esophagitis, which could become the drug’s third approved indication and unlock what’s viewed as a blockbuster opportunity.
Pharmaceutical company is working with Oracle to advance the use of AI and data analytics in medicine
AstraZeneca’s equity investment in Summit Therapeutics comes with plans for clinical trial collaborations. The deal brings AstraZeneca into a growing group of pharmaceutical compan...
Etcamah is the second oral “SERD” to recently fall short in first-line breast cancer, following a similar setback from Roche earlier this year.
Oracle today announced an agreement with AstraZeneca to explore how AI and real-world data can help clinicians identify eligible patients for clinical trials, accelerate evidence g...
Арбитражный суд Москвы отклонил иск шведской фармкомпании AstraZeneca к компаниям "Герофарм" и "АЗТ Фарма К.Б.", в котором она просила запретить ответчикам производить и вводить в...
Chinese biopharmaceutical firm Akeso announced on Wednesday that its immunotherapy drug had outperformed AstraZeneca’s Imfinzi in a head-to-head phase-three trial for biliary tract...
AstraZeneca and Amgen drug Tezspire met the goals of a Phase 3 test in eosinophilic esophagitis (EoE), a chronic disorder whose only approved biologic therapy is Sanofi’s Dupixent....
With all the doom and gloom surrounding the FTSE 100, it’s promising to see a major broker up its target for one of the index’s largest listings. The post While the m...
Positive high-level results from the Phase III CROSSING trial in patients with eosinophilic esophagitis (EoE) showed that AstraZeneca and Amgen's Tezspire (tezepelumab) demonstrate...
Hong Kong can attract more global biotech investments if the city builds up a new healthcare financial model, according to AstraZeneca, a Cambridge-based multinational pharmaceutic...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.